搜索临床试验以:Glutathione Transferase P1-1 inhibitor
总计103992个结果
-
Tibotec Pharmaceuticals, Ireland完全的TMC125-C214 研究为多种抗逆转录病毒方案失败的 HIV-1 感染患者提供了早期使用 TMC125 的机会,并将收集有关 TMC125 与其他抗逆转录病毒药物联合使用的长期安全性和耐受性的信息HIV-1美国, 比利时, 德国, 台湾, 西班牙, 墨西哥, 火鸡, 加拿大, 荷兰, 丹麦, 希腊, 瑞典, 大韩民国, 俄罗斯联邦, 波多黎各, 卢森堡
-
GlaxoSmithKline终止
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
DICE Therapeutics, Inc., a wholly owned subsidiary...Eli Lilly and Company招聘中
-
University of MalayaMinistry of Health, Malaysia未知
-
The George InstituteNational Health and Medical Research Council, Australia完全的
-
Royal College of Surgeons, IrelandEnterprise Ireland; Dublin City University未知
-
Federal Research Institute of Pediatric Hematology...主动,不招人骨髓增生异常综合征 | 幼年型粒单核细胞白血病 | 急性淋巴细胞白血病 | 成髓细胞白血病 | 恶性淋巴瘤 | 双表型急性白血病俄罗斯联邦
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Virginia Commonwealth UniversityMichael J. Fox Foundation for Parkinson's Research撤销
-
Vanderbilt University Medical Center撤销
-
Eastern Hepatobiliary Surgery Hospital完全的
-
Eastern Hepatobiliary Surgery Hospital完全的
-
Tibotec Pharmaceuticals, Ireland完全的
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
B.P. Koirala Institute of Health SciencesNepal Health Research Council完全的
-
University of PittsburghNational Institute on Drug Abuse (NIDA)招聘中
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan终止
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Eli Lilly and Company完全的
-
Ningbo No. 1 Hospital招聘中